• English
    • Welsh
  • English 
    • English
    • Welsh
  • Login
Search DSpace:
  • Home
  • Research at Cardiff Met
  • Library Services
  • Contact Us
View item 
  • DSpace home
  • Cardiff School of Sport and Health Sciences
  • Health and Risk Management
  • View item
  • DSpace home
  • Cardiff School of Sport and Health Sciences
  • Health and Risk Management
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?

Thumbnail
Author
Anbarasu, Anand
Ramaiah, Sudha
Livingstone, Paul
Date
2020-06-05
Acceptance date
2020-05-18
Type
Article
Publisher
Taylor and Francis
ISSN
2164-554X
Metadata
Show full item record
Abstract
The coronavirus disease (COVID-19) is resulting in millions of infected individuals with several hundred thousands dead throughout the world. Amidst all the havoc, one interesting observation in the present COVID-19 pandemic is the negligible symptoms in the young; particularly children below 10 years of age. We assume the extensive pediatric vaccination with MMR vaccines followed globally could have resulted in innate immune responses, e.g., induction of interferons (IFNs) and activated natural killer (NK) cells, thereby offering natural immunity against SARS-CoV-2 in the young population. Possible cross-protective innate immunity offered by MMR vaccination prompted us to suggest repurposing MMR vaccination for immuno-prophylaxis against COVID-19.
Journal/conference proceeding
Human Vaccines and Immunotherapeutics;
Citation
Anbarasu, A., Ramaiah, S. and Livingstone, P. (2020) 'Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?', Human Vaccines & Immunotherapeutics, pp.1-2.
URI
http://hdl.handle.net/10369/11109
DOI
https://doi.org/10.1080/21645515.2020.1773141
Description
Article published in Human Vaccines and Immunotherapeutics on 05 June 2020, freely available at: https://doi.org/10.1080/21645515.2020.1773141.
Rights
http://www.rioxx.net/licenses/all-rights-reserved
Sponsorship
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
Indian council of Medical Research (Government of India, agency) research grant IRIS ID: 2019-0810.
Collections
  • Health and Risk Management [392]

Related items

Showing items related by title, author, subject and abstract.

  • Thumbnail

    Meningitis C vaccine uptake by British undergraduates 

    Thirlaway, Kathryn; Lukeman, H. (Health Protection Agency in association with the Scottish Centre for Infection and Environmental Health, 2003-06-01)
    A new conjugated meningococcal group C vaccine became available in November 1999. This study set out to record the vaccination status of all first year undergraduates attending a university in South Wales in 2000-01 and ...
  • Thumbnail

    Modulation of the innate immune response by Middle East Respiratory Syndrome Coronavirus Spike protein 

    Al Rashdi, Mohmed Abdulla Omar (Cardiff Metropolitan University, 2017-06-01)
    Background: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was identified in 2012 as an emerging pathogen linked to patients presenting with serious respiratory illness complicated with renal impairment and to a ...
  • Thumbnail

    THE CYTOTOXIC EFFECT OF LUTEOLIN, WITH AND WITHOUT KAEMPFEROL, IN SIHA CERVICAL CANCER CELLS 

    Gunston, Sophie (Cardiff Metropolitan University, 2017-06-01)
    The human papillomavirus (HPV) is a highly transmissible virus with over 200 genotypes discovered, categorised based of their risk status. Recurrent infection with the carcinogenic high risk genotypes is responsible for ...

Browse

DSpace at Cardiff MetCommunities & CollectionsBy issue dateAuthorsTitlesSubjectsThis collectionBy issue dateAuthorsTitlesSubjects

My Account

Login

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors

DSpace software copyright © 2002-2015  DuraSpace
Contact us | Send feedback | Administrator